“It’s a riskier and more aggressive approach,” says Prashant Yadav, a vaccine supply-chain expert at the Center for Global Development, a Washington-based think-tank.

At first glance, it may seem as if the world will soon have more than enough COVID-19 vaccines. Manufacturers have produced approximately ten billion individual doses since states began approving inoculations in the middle of 2020.